Relmada Therapeutics Inc. (RLMD) at a glance

Relmada Therapeutics Inc. (RLMD) is a Healthcare company. It trades at $6.51. It does not pay a dividend. Vestovix scores it 52/100 overall. Its strongest dimension is Momentum (72/100) and its weakest is Income (40/100).

Price
$6.52
Market cap
n/a
P/E ratio
n/a
Dividend yield
None
Beta
n/a
52-week range
$0.52 to $8.00
Vestovix Score52/ 100How this works
Value
50
Growth
50
Income
40
Safety
60
Momentum
72